Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
ID: 341931Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/341931

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-213.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) program, aimed at supporting large-scale research initiatives that address critical questions related to aging. This funding opportunity encourages multidisciplinary collaboration among higher education institutions, nonprofits, and government entities, focusing on projects that integrate various components such as coordinating centers and clinical sites, particularly in areas like Alzheimer’s disease and health disparities. There is no limit on application budgets, but they must accurately reflect project needs, with a maximum project period of five years. Interested applicants should note that the submission deadline for the first round is January 25, 2023, and can find further details and application instructions at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-213-Full-Announcement.html
    PAR-22-213.html
    The Department of Health and Human Services is inviting applications for funding under the Complex Integrated Multi-Component Projects in Aging Research program (U19 Clinical Trial Optional). This opportunity, reissued as PAR-22-213, supports large-scale research projects involving integrated components addressing critical questions in aging. Targeted applicants include higher education institutions, nonprofits, and government entities, promoting multidisciplinary collaboration. The FOA seeks projects with various components, such as coordinating centers and clinical sites, focusing on aging-related studies, including Alzheimer’s disease, inter-organ communication, and health disparities. The funding mechanism emphasizes the necessity of cross-institutional integration to ensure proposed projects leverage diverse expertise. While there is no limit on application budgets, they must reflect actual project needs, and a maximum project period is set at five years. Key dates outline submission deadlines, with the first round on January 25, 2023. The document underscores compliance with strict application instructions, urging early submission for error corrections. This initiative highlights the NIH's commitment to advancing aging research through innovative, large-scale, and collaborative approaches.
    Similar Opportunities
    NIA Program Project Applications (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIA Program Project Grants (P01 Clinical Trial Optional), aimed at advancing research in aging-related scientific areas. Applicants must propose at least three interrelated research projects centered around a common theme, along with an administrative core to manage the initiative, addressing topics such as genetics, biology, and Alzheimer’s disease. This funding opportunity is crucial for fostering collaborative research efforts among established scientists and early-career researchers, ultimately contributing to the understanding and improvement of public health concerning aging. Interested organizations must submit their applications by September 7, 2025, and can find additional details and requirements at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Facilitating T1 Translational Aging Research funding opportunity, aimed at advancing new therapeutics for aging-related conditions through preclinical and early-phase human studies. This initiative focuses on two main project categories: traditional drug development and data-driven computational drug repurposing strategies, with the UG3 phase supporting planning and preliminary studies for up to two years, followed by the UH3 phase for implementation activities lasting up to three years. The funding opportunity is significant for improving health outcomes for older adults, with a total anticipated funding of $2.5 million available for up to five awards, and applications are due by January 10, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-054) aimed at advancing interdisciplinary research in aging through the development and utilization of novel research infrastructures. This initiative encourages applicants to propose projects that enhance the understanding of aging by fostering collaborations across various scientific disciplines, with a focus on producing tangible scientific results such as new knowledge or tools. The funding is particularly relevant for addressing significant aging-related questions and improving the management of age-related health issues. Eligible applicants include higher education institutions, nonprofits, and government entities, with a funding ceiling of $500,000 and a close date for applications set for December 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html.
    NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) to support investigator-initiated multi-site interventional clinical trials focused on aging-related research. This funding opportunity aims to foster innovative biomedical and behavioral studies that address the complexities of aging, particularly in populations with multiple chronic conditions and polypharmacy. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with an emphasis on rigorous trial designs that ensure ethical considerations and participant diversity. Interested parties should note that the application deadline is January 7, 2026, and further details can be found at the provided NIH grants link, with inquiries directed to grantsinfo@nih.gov.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)" aimed at advancing the science of aging through innovative research infrastructure. This initiative invites applications from a diverse range of eligible institutions to develop sustainable frameworks that address critical interdisciplinary questions in aging, with a focus on areas such as machine learning applications, health disparities, and behavioral aspects of aging. The funding mechanism provides up to five years of support, including two years for initial developmental activities and up to three years for expanded activities, with an award ceiling of $500,000. Interested applicants can find more information and application guidelines at the NIH website, and must submit their proposals by December 2, 2025, to be considered for this discretionary grant opportunity.
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies," aimed at enhancing research infrastructure to support interdisciplinary projects in aging science. This funding opportunity encourages the development of novel research partnerships and seeks applications that demonstrate significant advancements in research infrastructure, with a focus on biomedical, social, and behavioral research related to aging mechanisms. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with a funding cap of $500,000 per year for projects lasting up to five years. Interested parties can find more information and submit applications through Grants.gov, with a submission deadline of December 2, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies" (R61/R33 - Clinical Trial Optional) aimed at advancing interdisciplinary research in aging. This initiative encourages applicants to develop novel research infrastructure that addresses critical questions in aging through collaborative efforts across various disciplines, including biological aging and behavioral science. The funding is structured in two phases, providing up to $500,000 annually for initial activities over two years (R61) followed by three years for expanded activities (R33), with applications accepted from eligible institutions and organizations until December 3, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-218.html.
    Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alzheimer's Drug-Development Program (Funding Opportunity Number: PAR-24-223), aimed at supporting the preclinical and early-stage clinical development of innovative drug candidates for Alzheimer's disease (AD). The program focuses on funding activities such as medicinal chemistry, pharmacokinetics, and Investigational New Drug (IND)-enabling studies, with the goal of advancing viable therapies to address the significant public health challenge posed by AD. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and tribal organizations, with awards reaching up to $1.5 million over a period of up to five years for early-stage projects. Interested parties should submit their applications by November 5, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) to support the implementation of investigator-initiated multi-site interventional clinical trials focused on aging research. These trials must be hypothesis-driven and aim to address significant health challenges faced by populations aged 65 and older, particularly concerning multimorbidity and polypharmacy. This funding opportunity is crucial for advancing scientific understanding and improving health outcomes for older adults, with applications accepted for new, renewal, and resubmission proposals, and no budget limits as long as they align with project needs. Interested applicants can find more information and submit their proposals by January 7, 2026, and should direct inquiries to grantsinfo@nih.gov.